Which biomarkers for diagnosis and guidance of anti-infection treatment in sepsis?

Anaesthesist. 2021 Nov 12. doi: 10.1007/s00101-021-01067-7. Online ahead of print.ABSTRACTTo date no biomarker has been identified bringing together perfect sensitivity and specificity to discriminate between inflammation and infections. Since the 1930s new markers of tissue damage and endothelial damage have been identified but which are incapable of identifying infections in every clinical setting to enable initiation of early antibiotic treatment. In this review the most important classical biomarkers and upcoming new PCR-based approaches are addressed. These markers are highlighted with respect to special clinical settings and to control the success of antibiotic treatment. The issue of discrimination between inflammation and infection is not yet solved. Based on one single biomarker it is impossible to decide whether infection is the reason for the patient's worsening condition but the combination of biomarkers or the integration of new biomarkers may be a meaningful supplement. The measurement of different biomarkers of infection or inflammation is part of the routine in critical care and will be essential in the future.PMID:34767054 | DOI:10.1007/s00101-021-01067-7
Source: Der Anaesthesist - Category: Anesthesiology Authors: Source Type: research